RTW INVESTMENTS, LP Q1 2016 Filing
Filed May 11, 2016
Portfolio Value
$275.4B
Holdings
34
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (34 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALNYAlnylam Pharmaceuticals Inc | 866,379 | $54.4B | 19.74% | |
| 2 | INCYIncyte Corp | 379,415 | $27.5B | 9.98% | |
| 3 | —La Jolla Pharmaceutical Co | 1,169,065 | $24.4B | 8.87% | |
| 4 | —Achillion Pharmaceuticals Inc | 2,558,859 | $19.8B | 7.17% | |
| 5 | —Kite Pharma Inc | 343,503 | $15.8B | 5.73% | |
| 6 | OMEROmeros Corp | 891,522 | $13.7B | 4.97% | |
| 7 | —Avexis Inc | 473,374 | $12.9B | 4.68% | |
| 8 | —Dicerna Pharmaceuticals Inc | 2,026,894 | $10.9B | 3.94% | |
| 9 | AGENEURAgenus Inc | 2,414,524 | $10.0B | 3.65% | |
| 10 | —bluebird bio Inc | 226,371 | $9.6B | 3.49% | |
| 11 | —Five Prime Therapeutics Inc | 226,998 | $9.2B | 3.35% | |
| 12 | MRTXEURMirati Therapeutics Inc | 428,457 | $9.2B | 3.33% | |
| 13 | —Symmetry Surgical Inc | 919,680 | $9.1B | 3.29% | |
| 14 | ATRAGBXAtara Biotherapeutics Inc. | 473,126 | $9.0B | 3.27% | |
| 15 | BMYBristol-Myers Squibb Co | 109,701 | $7.0B | 2.54% | |
| 16 | BCRXBioCryst Pharmaceuticals Inc | 1,973,932 | $5.6B | 2.03% | |
| 17 | TLTiShares 20+ Year Treasury Bond ETF | 30,000 | $3.9B | 1.42% | |
| 18 | —Celldex Therapeutics Inc | 989,376 | $3.7B | 1.36% | |
| 19 | —Corium International Inc | 828,332 | $3.2B | 1.16% | |
| 20 | GBTUSDGlobal Blood Therapeutics Inc | 190,981 | $3.0B | 1.10% | |
| 21 | RGNXRegenxbio Inc | 241,323 | $2.6B | 0.95% | |
| 22 | —Lipocine Inc | 240,438 | $2.4B | 0.89% | |
| 23 | —Accelerate Diagnostics Inc | 117,176 | $1.7B | 0.61% | |
| 24 | —Invuity Inc | 212,808 | $1.5B | 0.56% | |
| 25 | —CytRx Corp | 513,092 | $1.4B | 0.50% | |
| 26 | 3M4Masimo Corp | 25,900 | $1.1B | 0.39% | |
| 27 | —MNKD 01/20/2017 PUT 3 | 4,385 | $899.0M | 0.33% | Put |
| 28 | —Biopharmx Corp | 700,636 | $764.0M | 0.28% | |
| 29 | MDRXAllscripts Healthcare Solutions Inc | 48,000 | $634.0M | 0.23% | |
| 30 | NTRANatera Inc | 31,693 | $302.0M | 0.11% | |
| 31 | —Nivalis Therapeutics Inc | 30,000 | $125.0M | 0.05% | |
| 32 | ADAPYAdaptimmune Therapeutics-adr | 7,691 | $63.0M | 0.02% | |
| 33 | NVROEURNVRO 05/20/2016 PUT 50 | 142 | $36.0M | 0.01% | Put |
| 34 | BRK/BBerkshire Hathaway Inc | 50 | $7.0M | 0.00% |